Machine learning assisted risk stratification of newly diagnosed multiple myeloma with respect to the VRd treatment

被引：0
|
作者：
Koo, Jamin [1 ]
Choi, Gyucheol [2 ]
Park, Sung-Soo [3 ]
Byun, Ja Min [4 ]
Lim, Sungwon [1 ]
Lee, Jong Cheol [5 ]
机构：
[1] ImpriMed Inc, Mountain View, CA USA
[2] ImpriMedKorea Inc, Seoul, South Korea
[3] Catholic Univ Korea, Seoul St Marys Hematol Hosp, Dept Hematol, Coll Med, Seoul, South Korea
[4] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Ulsan Univ, Ulsan, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-118
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [1] Update on risk stratification and treatment of newly diagnosed multiple myeloma
    Prashant Kapoor
    S. Vincent Rajkumar
    International Journal of Hematology, 2011, 94 : 310 - 320
  • [2] Update on risk stratification and treatment of newly diagnosed multiple myeloma
    Kapoor, Prashant
    Rajkumar, S. Vincent
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (04) : 310 - 320
  • [3] Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group
    Adrian Mosquera Orgueira
    Marta Sonia González Pérez
    Jose Diaz Arias
    Laura Rosiñol
    Albert Oriol
    Ana Isabel Teruel
    Joaquin Martinez Lopez
    Luis Palomera
    Miguel Granell
    Maria Jesus Blanchard
    Javier de la Rubia
    Ana López de la Guia
    Rafael Rios
    Anna Sureda
    Miguel Teodoro Hernandez
    Enrique Bengoechea
    María José Calasanz
    Norma Gutierrez
    Maria Luis Martin
    Joan Blade
    Juan-Jose Lahuerta
    Jesús San Miguel
    Maria Victoria Mateos
    Blood Cancer Journal, 12
  • [4] Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group
    Mosquera Orgueira, Adrian
    Gonzalez Perez, Marta Sonia
    Diaz Arias, Jose
    Rosinol, Laura
    Oriol, Albert
    Teruel, Ana Isabel
    Martinez Lopez, Joaquin
    Palomera, Luis
    Granell, Miguel
    Blanchard, Maria Jesus
    de la Rubia, Javier
    Lopez de la Guia, Ana
    Rios, Rafael
    Sureda, Anna
    Hernandez, Miguel Teodoro
    Bengoechea, Enrique
    Calasanz, Maria Jose
    Gutierrez, Norma
    Martin, Maria Luis
    Blade, Joan
    Lahuerta, Juan-Jose
    San Miguel, Jesus
    Mateos, Maria Victoria
    BLOOD CANCER JOURNAL, 2022, 12 (04)
  • [5] Individualized risk stratification in newly diagnosed multiple myeloma
    Rajanna, Arjun Raj
    Maura, Francesco
    Derkach, Andriy
    Ziccheddu, Bachisio
    Weinhold, Niels
    Maclachlan, Kylee
    Diamond, Benjamin
    Davies, Faith
    Boyle, Eileen
    Walker, Brian
    Pos, Alexandra
    Hulcrantz, Malin
    Silva, Ariosto
    Hampton, Oliver
    Teer, Jamie K.
    Bolli, Niccolo
    Jackson, Graham
    Kaiser, Martin
    Pawlyn, Charlotte
    Cook, Gordon
    Verducci, Dennis
    Kazandjian, Dickran
    Van Rhee, Fritz
    Usmani, Saad
    Shain, Kenneth H.
    Raab, Marc S.
    Morgan, Gareth
    Landgren, Ola
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma
    Maura, Francesco
    Rajanna, Arjun Raj
    Derkach, Andriy
    Ziccheddu, Bachisio
    Weinhold, Niels
    Maclachlan, Kylee H.
    Diamond, Benjamin
    Davies, Faith E.
    Boyle, Eileen
    Walker, Brian A.
    Poos, Alexandra M.
    Hultcrantz, Malin
    Silva, Ariosto Siqueira
    Hampton, Oliver
    Teer, Jamie
    Bolli, Niccolo
    Jackson, Graham
    Kaiser, Martin F.
    Pawlyn, Charlotte
    Cook, Gordon
    Verducci, Dennis
    Kazandjian, Dickran
    van Rhee, Frits
    Usmani, Saad
    Shain, Ken H.
    Raab, Marc S.
    Morgan, Gareth J.
    Landgren, Ola
    BLOOD, 2022, 140 : 1561 - 1563
  • [7] Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification
    Callander, Natalie S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 : 17 - 19
  • [8] Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
    Mellors, Patrick
    Binder, Moritz
    Ketterling, Rhett P.
    Griepp, Patricia
    Baughn, Linda B.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Haymann, Suzanne
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Hwa, Yi Lisa
    Fonder, Amie
    Hobbs, Miriam A.
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Lust, John A.
    Leung, Nelson
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD, 2019, 134
  • [9] VRd vs. VPd as induction therapy in high risk newly diagnosed multiple myeloma
    Li, Chun Yan
    Zhong, Long
    Chen, Dan Gui
    Yao, Fu Sheng
    Yan, Hong
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma
    Mao, Xuehan
    Xu, Yan
    Yan, Yuting
    Liu, Jiahui
    Fan, Huishou
    Sui, Weiwei
    Deng, Shuhui
    Li, Zengjun
    Qiu, Lugui
    An, Gang
    BLOOD, 2019, 134
12345